Camelot Portfolios LLC Acquires Shares of 1,833 iShares Biotechnology ETF (NASDAQ:IBB)
Camelot Portfolios LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,833 shares of the financial services provider’s stock, valued at approximately $249,000. Other large investors also recently […]